These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6739373)

  • 61. [Hormone therapy of male genital cancer (prostatic cancer)].
    Machida T; Ikemoto I
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2845-52. PubMed ID: 2444164
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Estramustine phosphate sodium.
    Hauser AR; Merryman R
    Drug Intell Clin Pharm; 1984 May; 18(5):368-74. PubMed ID: 6373212
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A randomized double blind crossover trial of diethylstilbestrol (DES) and estramustine phosphate (Emcyt) for stage D prostatic carcinoma.
    Benson RC; Gill GM; Cummings KB
    Semin Oncol; 1983 Sep; 10(3 Suppl 3):43-5. PubMed ID: 6364366
    [No Abstract]   [Full Text] [Related]  

  • 64. Estramustine phosphate in prostate cancer. Seminar.
    Urology; 1984 Jun; 23(6 Suppl):1-88. PubMed ID: 6730139
    [No Abstract]   [Full Text] [Related]  

  • 65. Estramustine for prostate cancer.
    Med Lett Drugs Ther; 1982 Aug; 24(615):74. PubMed ID: 7099111
    [No Abstract]   [Full Text] [Related]  

  • 66. Uptake of estramustine phosphate (estracyt) metabolites in prostatic cancer.
    Norlén BJ; Andersson SB; Björk P; Gunnarsson PO; Fritjofsson A
    J Urol; 1988 Nov; 140(5):1058-62. PubMed ID: 3172360
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer.
    Loening SA; Beckley S; Brady MF; Chu TM; deKernion JB; Dhabuwala C; Gaeta JF; Gibbons RP; McKiel CF; McLeod DG; Pontes JE; Prout GR; Scardino PT; Schlegel JU; Schmidt JD; Scott WW; Slack NH; Soloway MS; Murphy GP
    J Urol; 1983 May; 129(5):1001-6. PubMed ID: 6343629
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hormone changes in patients with prostatic carcinoma during treatment with estramustine phosphate.
    Fosså SD; Fosså J; Aakvaag A
    J Urol; 1977 Dec; 118(6):1013-8. PubMed ID: 926240
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Combined hormono/chemotherapy as primary treatment for metastatic prostate cancer: a randomized, multicenter study of orchiectomy alone versus orchiectomy plus estramustine phosphate. The Dutch Estracyt Study Group.
    Janknegt RA; Boon TA; van de Beek C; Grob P
    Urology; 1997 Mar; 49(3):411-20. PubMed ID: 9123707
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cooperative clinical trials of the National Prostatic Cancer Project: Protocol 900.
    Schmidt JD
    Prostate; 1984; 5(4):387-99. PubMed ID: 6377283
    [TBL] [Abstract][Full Text] [Related]  

  • 71. DNA content in cells aspirated from carcinoma of the prostate treated with oestrogenic compounds.
    Kjaer TB; Thommesen P; Frederiksen P; Bichel P
    Urol Res; 1979 Dec; 7(4):249-51. PubMed ID: 524561
    [No Abstract]   [Full Text] [Related]  

  • 72. Estramustine phosphate (Estracyt) treatment of T3-T4 prostatic carcinoma.
    Veronesi A; Zattoni F; Frustaci S; Galligioni E; Tirelli U; Trovó G; Tumolo S; Merlo A; Artuso G; Cosciani-Cunico S; Grigoletto E
    Prostate; 1982; 3(2):159-64. PubMed ID: 7088731
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A comparison of the effect of diethylstilbestrol with low dose estramustine phosphate in the treatment of advanced prostatic cancer: final analysis of a phase III trial of the European Organization for Research on Treatment of Cancer.
    Smith PH; Suciu S; Robinson MR; Richards B; Bastable JR; Glashan RW; Bouffioux C; Lardennois B; Williams RE; de Pauw M
    J Urol; 1986 Sep; 136(3):619-23. PubMed ID: 3525866
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A comparison of estramustine phosphate and streptozotocin in patients with advanced prostatic carcinoma who have had extensive irradiation.
    Murphy GP; Gibbons RP; Johnson DE; Loening SA; Prout GR; Schmidt JD; Bross DS; Chu TM; Gaeta JF; Saroff J; Scott WW
    J Urol; 1977 Aug; 118(2):288-91. PubMed ID: 142845
    [No Abstract]   [Full Text] [Related]  

  • 75. Estramustine phosphate vs diethylstilbestrol in the treatment of stage D prostate cancer.
    Benson RC; Cummings K
    Prog Clin Biol Res; 1989; 303():177-86. PubMed ID: 2674984
    [No Abstract]   [Full Text] [Related]  

  • 76. The EORTC Phase III trials in prostatic cancer.
    Robinson MR; Smith PH; Macaluso MP; Sylvester R; de Voogt H
    Prog Clin Biol Res; 1985; 185A():243-9. PubMed ID: 3898132
    [No Abstract]   [Full Text] [Related]  

  • 77. Effect of treatment on the expression of estramustine-binding protein (EMBP) in prostatic cancer patients: an immunohistochemical study.
    Flüchter SH; Nelde HJ; Björk P; Müntzing J; Bichler KH
    Prostate; 1989; 14(1):27-43. PubMed ID: 2648345
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Oral estramustine phosphate (Estracyt): a broad phase II study.
    Halpern J; Catane R
    J Med; 1984; 15(1):35-43. PubMed ID: 6593404
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Initial clinical studies with estramustine phosphate.
    Nilsson T; Müntzing J
    Urology; 1984 Jun; 23(6 Suppl):49-50. PubMed ID: 6375080
    [No Abstract]   [Full Text] [Related]  

  • 80. Estramustine phosphate as primary therapy for metastatic prostate cancer. Preliminary results of the University of Wisconsin trial.
    Benson RC
    Urology; 1984 Jun; 23(6 Suppl):69-72. PubMed ID: 6375084
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.